Medicamen Biotech Limited (MEDICAMEQ) — Working Capital to Net Assets Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Working Capital to Net Assets ratio of 50.0% as of September 2025. Working capital of Rs1.38 Billion (current assets of Rs2.23 Billion minus current liabilities of Rs855.86 Million) is measured against net assets of Rs2.75 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Medicamen Biotech Limited balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medicamen Biotech Limited Working Capital to Net Assets (2006–2025)
This chart shows how Medicamen Biotech Limited's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 50.0%, reflecting working capital of Rs1.38 Billion against net assets of Rs2.75 Billion INR. Check MEDICAMEQ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Medicamen Biotech Limited (2006–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medicamen Biotech Limited from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Medicamen Biotech Limited (MEDICAMEQ) total market value.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 40.6% | Rs863.84 Million | Rs2.13 Billion | Rs1.65 Billion | Rs781.65 Million | ▲ +4.3 pp |
| 2024 | 36.3% | Rs750.38 Million | Rs2.07 Billion | Rs1.60 Billion | Rs845.55 Million | ▼ -5.5 pp |
| 2023 | 41.8% | Rs807.89 Million | Rs1.93 Billion | Rs1.63 Billion | Rs825.74 Million | ▲ +7.4 pp |
| 2022 | 34.4% | Rs503.47 Million | Rs1.46 Billion | Rs1.23 Billion | Rs726.91 Million | ▲ +2.2 pp |
| 2021 | 32.2% | Rs427.59 Million | Rs1.33 Billion | Rs960.33 Million | Rs532.74 Million | ▼ -7.1 pp |
| 2020 | 39.3% | Rs476.48 Million | Rs1.21 Billion | Rs1.04 Billion | Rs564.84 Million | ▼ -15.7 pp |
| 2019 | 55.0% | Rs476.25 Million | Rs866.34 Million | Rs961.68 Million | Rs485.44 Million | ▼ -11.7 pp |
| 2018 | 66.7% | Rs497.78 Million | Rs746.08 Million | Rs909.86 Million | Rs412.08 Million | ▲ +26.7 pp |
| 2017 | 40.0% | Rs107.14 Million | Rs267.81 Million | Rs533.80 Million | Rs426.67 Million | ▲ +21.3 pp |
| 2016 | 18.7% | Rs33.52 Million | Rs179.09 Million | Rs405.95 Million | Rs372.43 Million | ▼ -3.2 pp |
| 2015 | 21.9% | Rs37.66 Million | Rs171.85 Million | Rs485.08 Million | Rs447.43 Million | ▲ +44.0 pp |
| 2014 | -22.1% | Rs-36.59 Million | Rs165.38 Million | Rs419.48 Million | Rs456.07 Million | ▲ +14.9 pp |
| 2013 | -37.0% | Rs-58.21 Million | Rs157.17 Million | Rs419.09 Million | Rs477.31 Million | ▼ -28.0 pp |
| 2012 | -9.0% | Rs-18.13 Million | Rs201.01 Million | Rs453.02 Million | Rs471.15 Million | ▼ -47.0 pp |
| 2011 | 38.0% | Rs77.62 Million | Rs204.12 Million | Rs468.25 Million | Rs390.63 Million | ▼ -16.1 pp |
| 2010 | 54.2% | Rs88.07 Million | Rs162.61 Million | Rs370.11 Million | Rs282.03 Million | ▲ +24.5 pp |
| 2009 | 29.7% | Rs38.45 Million | Rs129.60 Million | Rs274.93 Million | Rs236.47 Million | ▲ +41.9 pp |
| 2008 | -12.3% | Rs-14.19 Million | Rs115.83 Million | Rs343.47 Million | Rs357.67 Million | ▼ -13.0 pp |
| 2007 | 0.8% | Rs790.00K | Rs100.73 Million | Rs312.80 Million | Rs312.01 Million | ▼ -27.3 pp |
| 2006 | 28.1% | Rs24.04 Million | Rs85.67 Million | Rs230.54 Million | Rs206.49 Million | — |